Please login to the form below
PMEA 2011: Photo Gallery (thumbnails)
PMEA 2011 - Photo Gallery
You can also view the photos as a slideshow or select an image by reference number from the slideshow page.
To order a high resolution print of an image call +44 (0)1372 414200 or email us quoting the reference number
PMEA 2011 1
PMEA 2011 2
PMEA 2011 3
PMEA 2011 4
PMEA 2011 5
PMEA 2011 6
PMEA 2011 7
PMEA 2011 8
PMEA 2011 9
PMEA 2011 10
PMEA 2011 11
PMEA 2011 12
PMEA 2011 13
PMEA 2011 14
PMEA 2011 15
PMEA 2011 16
PMEA 2011 17
PMEA 2011 18
PMEA 2011 19
PMEA 2011 20
PMEA 2011 21
PMEA 2011 22
PMEA 2011 23
PMEA 2011 24
PMEA 2011 25
PMEA 2011 26
PMEA 2011 27
PMEA 2011 28
PMEA 2011 29
PMEA 2011 30
PMEA 2011 31
PMEA 2011 32
PMEA 2011 33
PMEA 2011 34
PMEA 2011 35
PMEA 2011 36
PMEA 2011 37
PMEA 2011 38
PMEA 2011 39
PMEA 2011 40
PMEA 2011 41
PMEA 2011 42
PMEA 2011 43
PMEA 2011 44
PMEA 2011 45
PMEA 2011 46
PMEA 2011 47
PMEA 2011 48
PMEA 2011 49
PMEA 2011 50
PMEA 2011 51
PMEA 2011 52
PMEA 2011 53
PMEA 2011 54
PMEA 2011 55
PMEA 2011 56
PMEA 2011 57
PMEA 2011 58
PMEA 2011 59
PMEA 2011 60
PMEA 2011 61
PMEA 2011 62
PMEA 2011 63
Sponsors
Subscribe to our email news alerts
Featured jobs
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- Takeda’s dengue vaccine receives MHRA approval for those aged four years and older
- Sandoz’s biosimilar denosumab application accepted by FDA for osteoporosis
- Novartis’ Cosentyx shows continued improvement in hidradenitis suppurativa patients
- NHS urges people yet to receive their COVID-19 booster to come forward
- Biosimilars and beyond: innovating for improved patient outcomes
- Gilead’s Trodelvy approved by FDA for metastatic breast cancer
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Why female mentorship is so powerful in pharma
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- Europe’s cancer community publishes new report on transforming patient care
- Digital technology: a significant change in healthcare innovation
- Assessing the value of interim analyses in clinical trials
PMHub
Evoke Kyne
Evoke Kyne is an award-winning communications agency that harnesses insight, experience and creativity to advance health and wellbeing around the world. We were founded on the belief that...
Latest intelligence
- Biosimilars and beyond: innovating for improved patient outcomes
- How Europe’s biosimilar landscape has rapidly evolved over the last two decades, bringing biological medicines to more patients than ever before...
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
